Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Cardiorespiratory Fitness and Risk of Fatty Liver: The Young Finns Study.

Pälve KS, Pahkala K, Suomela E, Aatola H, Hulkkonen J, Juonala M, Lehtimäki T, Rönnemaa T, Viikari JSA, Kähönen M, Hutri-Kähönen N, Telama R, Tammelin T, Raitakari OT.

Med Sci Sports Exerc. 2017 Sep;49(9):1834-1841. doi: 10.1249/MSS.0000000000001288.

PMID:
28398943
2.

Detection of a G>C single nucleotide polymorphism within a repetitive DNA sequence by high-resolution DNA melting.

Schmidt U, Hulkkonen J, Naue J.

Int J Legal Med. 2016 Sep;130(5):1181-4. doi: 10.1007/s00414-016-1350-3. Epub 2016 Mar 14.

PMID:
26972692
3.

Determinants of exercise peak arterial blood pressure, circulatory power, and exercise cardiac power in a population based sample of Finnish male and female aged 30 to 47 years: the Cardiovascular Risk in Young Finns Study.

Hulkkonen J, Aatola H, Pälve K, Lehtimäki T, Hutri-Kähönen N, Viikari JS, Raitakari OT, Kähönen M.

BMC Cardiovasc Disord. 2014 Mar 13;14:35. doi: 10.1186/1471-2261-14-35.

4.

Host cell Golgi anti-apoptotic protein (GAAP) and growth of Chlamydia pneumoniae.

Markkula E, Hulkkonen J, Penttilä T, Puolakkainen M.

Microb Pathog. 2013 Jan;54:46-53. doi: 10.1016/j.micpath.2012.09.004. Epub 2012 Sep 21.

PMID:
23000903
5.

Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study.

Aatola H, Hutri-Kähönen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T, Taittonen L, Lehtimäki T, Raitakari OT, Kähönen M.

Hypertension. 2010 Mar;55(3):806-11. doi: 10.1161/HYPERTENSIONAHA.109.145102. Epub 2010 Jan 18.

PMID:
20083727
6.

Polymorphism in the IL10 promoter region and early markers of atherosclerosis: the Cardiovascular Risk in Young Finns Study.

Heiskanen M, Kähönen M, Hurme M, Lehtimäki T, Mononen N, Juonala M, Hutri-Kähönen N, Viikari J, Raitakari O, Hulkkonen J.

Atherosclerosis. 2010 Jan;208(1):190-6. doi: 10.1016/j.atherosclerosis.2009.06.032. Epub 2009 Jul 8.

PMID:
19700159
7.

Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.

Riikola A, Sipilä K, Kähönen M, Jula A, Nieminen MS, Moilanen L, Kesäniemi YA, Lehtimäki T, Hulkkonen J.

Atherosclerosis. 2009 Dec;207(2):466-70. doi: 10.1016/j.atherosclerosis.2009.06.004. Epub 2009 Jun 11.

PMID:
19592000
8.

Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure.

Palmio J, Suhonen J, Keränen T, Hulkkonen J, Peltola J, Pirttilä T.

Seizure. 2009 Sep;18(7):474-7. doi: 10.1016/j.seizure.2009.04.006. Epub 2009 May 9.

9.

Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: A video-EEG study.

Alapirtti T, Rinta S, Hulkkonen J, Mäkinen R, Keränen T, Peltola J.

J Neurol Sci. 2009 May 15;280(1-2):94-7. doi: 10.1016/j.jns.2009.02.355. Epub 2009 Mar 9.

PMID:
19272615
10.

Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.

Hulkkonen J, Lehtimäki T, Mononen N, Juonala M, Hutri-Kähönen N, Taittonen L, Marniemi J, Nieminen T, Viikari J, Raitakari O, Kähönen M.

Atherosclerosis. 2009 Apr;203(2):454-8. doi: 10.1016/j.atherosclerosis.2008.07.014. Epub 2008 Jul 25.

PMID:
18774574
11.

Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis.

Samani NJ, Raitakari OT, Sipilä K, Tobin MD, Schunkert H, Juonala M, Braund PS, Erdmann J, Viikari J, Moilanen L, Taittonen L, Jula A, Jokinen E, Laitinen T, Hutri-Kähönen N, Nieminen MS, Kesäniemi YA, Hall AS, Hulkkonen J, Kähönen M, Lehtimäki T.

Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1679-83. doi: 10.1161/ATVBAHA.108.170332. Epub 2008 Jul 3.

PMID:
18599798
12.

Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study.

Palmio J, Keränen T, Alapirtti T, Hulkkonen J, Mäkinen R, Holm P, Suhonen J, Peltola J.

Epilepsy Res. 2008 Oct;81(2-3):155-60. doi: 10.1016/j.eplepsyres.2008.05.006. Epub 2008 Jul 1.

PMID:
18595663
13.

Childhood cat exposure-related tolerance is associated with IL1A and IL10 polymorphisms.

Karjalainen J, Virta M, Pessi T, Hulkkonen J, Nieminen MM, Hurme M.

J Allergy Clin Immunol. 2005 Jul;116(1):223-5. No abstract available.

PMID:
15990800
14.

Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.

Vilpo J, Tobin G, Hulkkonen J, Hurme M, Thunberg U, Sundström C, Vilpo L, Rosenquist R.

Eur J Haematol. 2005 Jul;75(1):34-40.

PMID:
15946308
15.

The effect of mannan-binding lectin variant alleles on coronary artery reactivity in healthy young men.

Aittoniemi J, Fan YM, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Knuuti J, Hulkkonen J, Hurme M, Lehtimäki T.

Int J Cardiol. 2004 Nov;97(2):317-8.

PMID:
15458704
16.

Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.

Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, Pöllänen P, Lehtimäki T.

Rheumatology (Oxford). 2004 Dec;43(12):1476-9. Epub 2004 Aug 17.

PMID:
15316122
17.

The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients.

Hulkkonen J, Koskikallio E, Rainesalo S, Keränen T, Hurme M, Peltola J.

Epilepsy Res. 2004 Apr-May;59(2-3):199-205.

PMID:
15246121
18.

Urinary matrix metalloproteinase-9 and interleukin-6 and renal manifestations of primary Sjogren's syndrome.

Pertovaara M, Hulkkonen J, Hurme M, Lehtimäki T, Pasternack A.

Rheumatology (Oxford). 2004 Jun;43(6):807-8. No abstract available.

PMID:
15163834
19.

The association between mannan-binding lectin gene alleles and celiac disease.

Iltanen S, Mäki M, Collin P, Mustalahti K, Kaukinen K, Partanen J, Hulkkonen J, Hurme M, Aittoniemi J.

Am J Gastroenterol. 2003 Dec;98(12):2808-9. No abstract available.

PMID:
14687843
20.

Polymorphism of the tumour necrosis factor-alpha gene at position -308 and renal manifestations of primary Sjögren's syndrome.

Pertovaara M, Hulkkonen J, Antonen J, Holopainen P, Laippala P, Pasternack A, Hurme M.

Rheumatology (Oxford). 2004 Jan;43(1):106-7. No abstract available.

PMID:
14681562

Supplemental Content

Loading ...
Support Center